Patrick C. Still, Ph.D.
Affiliations: | 2013 | Pharmacy | Ohio State University, Columbus, Columbus, OH |
Area:
Biochemistry, Pharmacology, Analytical Chemistry, OncologyGoogle:
"Patrick Still"Mean distance: (not calculated yet)
Parents
Sign in to add mentor| A Douglas Kinghorn | grad student | 2013 | Ohio State | |
| (Cytotoxic Alkaloids from Microcos paniculata with Activity at Neuronal Nicotinic Receptors.) | ||||
| Phillip Crews | post-doc | 2013-2015 | UC Santa Cruz | |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Lorig-Roach N, Still PC, Coppage D, et al. (2017) Evaluating Nitrogen-Containing Biosynthetic Products Produced by Saltwater Culturing of Several California Littoral Zone Gram-Negative Bacteria. Journal of Natural Products |
| Theodore CM, Lorig-Roach N, Still PC, et al. (2015) Biosynthetic products from a nearshore-derived gram-negative bacterium enable reassessment of the kailuin depsipeptides. Journal of Natural Products. 78: 441-52 |
| Pérez LB, Still PC, Naman CB, et al. (2014) Investigation of Vietnamese plants for potential anticancer agents. Phytochemistry Reviews : Proceedings of the Phytochemical Society of Europe. 13: 727-739 |
| Still PC, Johnson TA, Theodore CM, et al. (2014) Scrutinizing the scaffolds of marine biosynthetics from different source organisms: Gram-negative cultured bacterial products enter center stage. Journal of Natural Products. 77: 690-702 |
| Still PC, Yi B, González-Cestari TF, et al. (2013) Alkaloids from Microcos paniculata with cytotoxic and nicotinic receptor antagonistic activities. Journal of Natural Products. 76: 243-9 |
| Ren Y, Wei M, Still PC, et al. (2012) Synthesis and Antitumor Activity of Ellagic Acid Peracetate. Acs Medicinal Chemistry Letters. 3: 631-636 |
| Lucas DM, Still PC, Pérez LB, et al. (2010) Potential of plant-derived natural products in the treatment of leukemia and lymphoma. Current Drug Targets. 11: 812-22 |